<DOC>
	<DOC>NCT00405431</DOC>
	<brief_summary>The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.</brief_summary>
	<brief_title>Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?</brief_title>
	<detailed_description>Continued use of glaucoma drops can alter the outer surface of the eye and result in swelling and irritation, changing the structure of the eye. This structural change has been found to be a significant risk factor for the failure of glaucoma surgery. A comparison of how well patients do after glaucoma surgery depending on whether they use Restasis (the only prescription medication approved by the FDA for treating dry eye) or artificial tears (which can be purchased without a prescription) for 6 months following their surgery.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patients with uncontrolled glaucoma scheduled for filtering surgery Under 18 years of age Unable to understand informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>glaucoma filtering surgery</keyword>
	<keyword>restasis</keyword>
	<keyword>conjunctival inflammation</keyword>
</DOC>